Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
21.1%
% of FXH's 77 holdings also in WDNA
19.0%
% of WDNA's 90 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.0% | 3.7% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.9% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 2.2% | 1.7% | 1.7% |
|
AMGEN INC | 1.7% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to WDNA
|
TENET HEALTHCARE CORP | 2.5% |
|
PENUMBRA, INC. | 2.5% |
|
CARDINAL HEALTH INC | 2.5% |
|
EXELIXIS INC | 2.5% |
|
DOXIMITY, INC. CLASS A | 2.4% |
|
CIGNA CORPORATION | 2.3% |
|
CENTENE CORP | 2.3% |
|
INSULET CORP | 2.2% |
|
MOLINA HEALTHCARE INC | 2.2% |
 |
JAZZ PHARMACEUTICALS PLC | 2.2% |
FXH Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
GILEAD SCIENCES INC | -1.9% |
|
NATERA INC | -1.7% |
 |
NOVARTIS AG | -1.7% |